Randall Pellish to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Randall Pellish has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.095
-
Juillerat P, Wasan SK, Fowler SA, Friedman S, Pabby VK, Coukas JA, Barto AE, Pellish R, Germansky KA, Cheifetz AS, Korzenik JR, Farraye FA, Yajnik V. Efficacy and safety of natalizumab in Crohn's disease patients treated at 6 Boston academic hospitals. Inflamm Bowel Dis. 2013 Oct; 19(11):2457-63.
Score: 0.095